Cite
HARVARD Citation
Manzo, A. et al. (n.d.). Serum levels of CXCL13 are associated with ultrasonographic synovitis and predict power doppler persistence in early rheumatoid arthritis treated with non-biological disease-modifying antirheumatic drugs. Annals of the rheumatic diseases. pp. A12-A13. [Online].